Felipe Duran
Vermogen: 68 351 $ op 31-05-2026
Vermogen: 68 351 $ op 31-05-2026
Felipe Duran is currently Chief Financial Officer at iBio, Inc. since 2023.
Formerly, Mr. Duran was Chief Financial Officer-Lupin Latin America at Lupin Pharmaceuticals, Inc. from 2016 to 2021 and Manager-Financial Planning & Analysis at Noven Pharmaceuticals, Inc. Education includes undergraduate and MBA degrees from the University of Miami.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IBIO, INC. 0,1% | 19-03-2026 | 35.974 ( 0,1% ) | 68 351 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IBIO, INC. | Financieel Directeur/CFO | 13-02-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes generic formulations, biotechnology products & APIs | Financieel Directeur/CFO | 01-05-2021 |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Commercial Services |
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes generic formulations, biotechnology products & APIs | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau